Literature DB >> 31070697

Evaluation of Prolonged vs Short Courses of Antibiotic Prophylaxis Following Ear, Nose, Throat, and Oral and Maxillofacial Surgery: A Systematic Review and Meta-analysis.

Martinus C Oppelaar1, Christian Zijtveld1, Saskia Kuipers1, Jaap Ten Oever2, Jimmie Honings3, Willem Weijs4, Heiman F L Wertheim1.   

Abstract

Importance: Antibiotic prophylaxis is widely used after surgical procedures operating on the mucosal tissues of the aerodigestive tract, but the optimal duration of these prophylactic therapies is often unclear. Objective: To compare short-course antibiotic prophylaxis (≤24 hours) vs extended-course antibiotic prophylaxis (≥72 hours) after ear, nose, throat, and oral and maxillofacial surgery. Data Sources and Study Selection: Literature searches of PubMed were completed in October 2017 and included prospective trials that compared antibiotic prophylaxis courses of 24 hours or less vs 72 hours or more after ear, nose, throat, and oral and maxillofacial surgery. Some studies were also handpicked from reference lists of studies found with the initial search terms. All analysis was performed between September 2017 and October 2018. Data Extraction and Synthesis: All review stages were conducted in consensus by 2 reviewers. Data extraction and study quality assessment were performed with the Cochrane data extraction form and the Cochrane risk of bias tool. Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were used for reporting. The fixed-effects Mantel-Haenszel method was used for meta-analysis. Main Outcomes and Measures: Relative risk (RR) of surgical site infections, microbial origins of surgical site infections, adverse events, duration of hospital stay, and treatment costs.
Results: Included in the meta-analysis were 21 articles with a cumulative 1974 patients. In patients receiving 24 hours or shorter vs 72 hours or longer antibiotic prophylaxis regimens, no significant difference was found in the occurrence of postoperative infections in the pooled population (RR, 0.90; 95% CI, 0.67-1.19), or in the ear, nose, throat (RR, 0.89; 95% CI, 0.54-1.45), and oral and maxillofacial populations (RR, 0.88; 95% CI, 0.63-1.21), separately. No heterogeneity was observed overall or in the subgroups. Patients receiving extended-course antibiotic prophylaxis were significantly more likely to develop adverse events unrelated to the surgical site (RR, 2.40; 95% CI, 1.20-3.54). Conclusions and Relevance: No difference was found in the occurrence of postoperative infections between short-course and extended-course antibiotic prophylaxis after ear, nose, throat, and oral and maxillofacial surgery. Therefore, a short course of antibiotic prophylaxis is recommended unless documented conditions are present that would be best treated with an extended course. Using short-course antibiotics could avoid additional adverse events, antibiotic resistance development, and higher hospital costs. Future research should focus on identifying risk groups that might benefit from prolonged prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31070697      PMCID: PMC6512286          DOI: 10.1001/jamaoto.2019.0879

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  33 in total

1.  Audit of the use of antimicrobial prophylaxis in nasal surgery at a specialist Australian hospital.

Authors:  Stephen J Colgan; Celene Mc Mullan; Geoffrey E Davies; Andrew M Sizeland
Journal:  ANZ J Surg       Date:  2005-12       Impact factor: 1.872

2.  Antibiotic prophylaxis in septorhinoplasty? A prospective, randomized study.

Authors:  Gunesh P Rajan; Neil Fergie; Ursin Fischer; Manuel Romer; Vladeta Radivojevic; Geoffrey K Hee
Journal:  Plast Reconstr Surg       Date:  2005-12       Impact factor: 4.730

3.  Perioperative antibiotic usage by facial plastic surgeons: national survey results and comparison with evidence-based guidelines.

Authors:  Lisa Danielle Grunebaum; David Reiter
Journal:  Arch Facial Plast Surg       Date:  2006 Mar-Apr

4.  Clinical practice guidelines for antimicrobial prophylaxis in surgery.

Authors:  Dale W Bratzler; E Patchen Dellinger; Keith M Olsen; Trish M Perl; Paul G Auwaerter; Maureen K Bolon; Douglas N Fish; Lena M Napolitano; Robert G Sawyer; Douglas Slain; James P Steinberg; Robert A Weinstein
Journal:  Surg Infect (Larchmt)       Date:  2013-03-05       Impact factor: 2.150

5.  The role of postoperative prophylactic antibiotics in the treatment of facial fractures: a randomized, double-blind, placebo-controlled pilot clinical study. Part 2: Mandibular fractures in 59 patients.

Authors:  Benoit Schaller; Poh Luon Soong; Jürgen Zix; Tateyuki Iizuka; Olivier Lieger
Journal:  Br J Oral Maxillofac Surg       Date:  2013-09-03       Impact factor: 1.651

Review 6.  Antibiotic Prophylaxis in Clean-Contaminated Head and Neck Surgery: A Systematic Review and Meta-analysis.

Authors:  Peter M Vila; Joseph Zenga; Ryan S Jackson
Journal:  Otolaryngol Head Neck Surg       Date:  2017-07-11       Impact factor: 3.497

7.  Cefotaxime prophylaxis in major non-contaminated head and neck surgery: one-day vs. seven-day therapy.

Authors:  E Mustafa; A Tahsin
Journal:  J Laryngol Otol       Date:  1993-01       Impact factor: 1.469

8.  [Comparative study of clinical effectiveness of antibiotic prophylaxis in aseptic mouth-jaw- and facial surgery].

Authors:  R E Cioacã; A Bucur; C Coca-Nicolae; C A V Coca
Journal:  Mund Kiefer Gesichtschir       Date:  2002-09

9.  Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck.

Authors:  William R Carroll; David Rosenstiel; Jobe R Fix; Jorge de la Torre; Joel S Solomon; Brian Brodish; Eben L Rosenthal; Tad Heinz; Santosh Niwas; Glenn E Peters
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-07

10.  The role of postoperative prophylactic antibiotics in the treatment of facial fractures: a randomised, double-blind, placebo-controlled pilot clinical study. Part 1: orbital fractures in 62 patients.

Authors:  Jürgen Zix; Benoit Schaller; Tateyuki Iizuka; Olivier Lieger
Journal:  Br J Oral Maxillofac Surg       Date:  2012-09-12       Impact factor: 1.651

View more
  8 in total

1.  Concentration standardization improves the capacity of drainage CRP and IL-6 to predict surgical site infections.

Authors:  Xiaoqin Bi; Yan Li; Jie Lin; Chunjie Li; Jiping Li; Yubin Cao
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-26

2.  [Postoperative treatment following paranasal sinus surgery].

Authors:  Thomas S Kühnel; Werner G Hosemann; Rainer Weber
Journal:  HNO       Date:  2021-05-03       Impact factor: 1.284

Review 3.  Systemic Antibiotic Prophylaxis in Maxillofacial Trauma: A Scoping Review and Critical Appraisal.

Authors:  Femke Goormans; Ruxandra Coropciuc; Maximilien Vercruysse; Isabel Spriet; Robin Willaert; Constantinus Politis
Journal:  Antibiotics (Basel)       Date:  2022-04-05

4.  Winds of Change in Antibiotic Therapy following Orthognathic Surgery.

Authors:  Oren Peleg; Reema Mahmoud; Clariel Ianculovici; Shimrit Arbel; Shlomi Kleinman; Amir Shuster
Journal:  Medicina (Kaunas)       Date:  2022-02-10       Impact factor: 2.430

5.  Prophylactic Antibiotic Practices in Common Otologic Surgeries in Iran.

Authors:  Mohammad Faramarzi; Ali Faramarzi; Sareh Roosta; Nikta Rabiei; Hossein Faramarzi
Journal:  Iran J Otorhinolaryngol       Date:  2021-11

6.  Antimicrobial Prescription Patterns among Oral Implantologists of Kerala, India: A Cross-Sectional Survey.

Authors:  Annie Kitty George; Vivek Narayan; Betsy Joseph; Bindya Balram; Sukumaran Anil
Journal:  J Pharm Bioallied Sci       Date:  2022-07-13

7.  Dentists' Habits of Antibiotic Prescribing May be Influenced by Patient Requests for Prescriptions.

Authors:  Aceil Al-Khatib; Raneem Ahmad AlMohammad
Journal:  Int J Dent       Date:  2022-08-22

8.  Prolonged antibiotic prophylaxis in tissue reconstruction using autologous fat grafting: Is there a benefit for wound healing?

Authors:  Evi M Morandi; Selina Winkelmann; Lucie Dostal; Isabel Radacki; Ulrich M Rieger; Benedikt Bauer; Ralph Verstappen; Dolores Wolfram; Thomas Bauer
Journal:  Int Wound J       Date:  2021-06-09       Impact factor: 3.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.